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Abstract
Background: Reports of inadequate cancer patient care have given rise to various interventions to support cancer care
pathways which, overall, seem poorly studied. Case management (CM) is one method that may support a cost-effective, high-
quality patient-centred treatment and care.
The purpose of this article was to summarise intervention characteristics, outcomes of interest, results, and validity components
of the published randomized controlled trials (RCTs) examining CM as a method for optimizing cancer care pathways.
Methods:  PubMed, Embase, Web of Science, CINAHL and The Cochrane Central Register of Controlled Trials were
systematically searched for RCTs published all years up to August 2008. Identified papers were included if they passed the
following standards. Inclusion criteria: 1) The intervention should meet the criteria for CM which includes multidisciplinary
collaboration, care co-ordination, and it should include in-person meetings between patient and the case manager aimed at
supporting, informing and educating the patient. 2) The intervention should focus on cancer patient care. 3) The intervention
should aim to improve subjective or objective quality outcomes, and effects should be reported in the paper.
Exclusion criteria: Studies centred on cancer screening or palliative cancer care.
Data extraction was conducted in order to obtain a descriptive overview of intervention characteristics, outcomes of interest
and findings. Elements of CONSORT guidelines and checklists were used to assess aspects of study validity.
Results: The searches identified 654 unique papers, of which 25 were retrieved for scrutiny. Seven papers were finally included.
Intervention characteristics, outcomes studied, findings and methodological aspects were all very diverse.
Conclusion: Due to the scarcity of papers included (seven), significant heterogeneity in target group, intervention setting,
outcomes measured and methodologies applied, no conclusions can be drawn about the effect of CM on cancer patient care.
It is a major challenge that CM shrouds in a "black box", which means that it is difficult to determine which aspect(s) of 
interventions contribute to overall effects. More trials on rigorously developed CM interventions (opening up the "black box") 
are needed as is the re-testing of interventions and outcomes studied in various settings.
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Background
Case management (CM) is an expanding organizational
approach used to optimize the quality of treatment and
care for individuals within complex patient groups [1].
Denmark has seen the launch of several CM projects
intended to improve the cancer trajectory. However, a sys-
tematic literature review of the studies evaluating the
effect of CM applied on cancer patient treatment and care
does not exist.
Donabedian proposed the integration of aspects of struc-
ture, process and outcomes when evaluating quality of
care [2], and multidimensional assessment of quality now
seems to have become generally accepted [3]. Examples of
inadequate cancer treatment and care categorised based
on theses aspects are given below:
Structure
Concomitantly with the expansion of treatment options
(owing, among others, to advances in medical knowledge
and the introduction of technological equipment) lack of
specially trained staff evidently hampers better treat-
ment[3].
Process
Evaluations of treatment and care indicate that cancer
patients and their relatives do not receive the support and
information about diagnosis, treatment and postopera-
tive course necessary for a satisfactory course and rehabil-
itation [4,5]. Moreover, considerable delay exists at all
stages of diagnosis and treatment [6,7], which is also
assumed to influence prognosis [8,9].
Outcomes
Mortality from cancer diagnoses vary substantially
between countries [10] Moreover, cancer patients and
their relatives suffer from poor physical, psychological
and social conditions, which could probably be
improved.
Basically, the purpose of CM is to link and optimize qual-
ity and cost-effective care in both hospital and community
settings [11]. CM is increasingly being regarded as a useful
approach for remedying health care system inadequacies
[1,11,12]. Definitions and specifications of CM-models
are numerous [11,13]. The following is a mainstream def-
inition: " [case management] is a collaborative process that
assesses, plans, implements, coordinates, monitors, and evalu-
ates the options and services required to meet the client's health
and human service needs. It is characterized by advocacy, com-
munication, and resource management and promotes quality
and cost-effective interventions and outcomes." [14]
Approaches to describe CM models also differ. One way
draws on a conception-operation framework that involves
three categories: 1. a brokerage model (whose primary
focus is advocacy and linking of services and needs); 2. a
social entrepreneurship model (where resource and budg-
etary control are central), or 3. a key-worker/care coordi-
nator model (stressing the case manager functioning
within an interdisciplinary team) [11]. Other ways of
describing a CM model originate in the setting (hospital-
based, hospital-to-community-based or community-
based) [15,16] or in the disease (disease-specific context).
Some CM models rely on interdisciplinary standards of
care, critical pathways or disease management pro-
grammes, whereas the case manager in other models is
merely the tool mapping client care [11,17]. Finally, CM
models can be specified on the basis of activities per-
formed (basic and advanced CM) [18], the mode of con-
tact (contact per telephone, in-person meetings,
accompaniment), etc. It should be noted that a model can
fall simultaneously within several different frameworks.
CM is carried out by a pro-active, supportive, facilitating,
multidisciplinary health care professional (or team). The
case manager, most often a nurse [11], is exclusively com-
mitted to assist patients navigate the increasingly special-
ized and fragmented health care system. Seamless
information, communication, coordination, patient
involvement and shared decision-making ensure that the
patient experiences a coherent and individually tailored
care pathway within the existing framework of the health
care system. Delivery of the right health care resources at
the right time is essential [15-17].
In spite of the absence of a proper definition of where and
how to introduce CM, attention to the concept generally
expands [18]. Hence, decision makers, health profession-
als and patient societies often support the idea of using
CM. However, we need to address the question of what
constitutes the scientific basis for the effectiveness of CM
among patient groups suffering from cancer [19]. The pur-
pose of this paper is to systematically identify all pub-
lished randomized controlled trials of CM-like
interventions applied in cancer patient care and to present
characteristics, effects studied and the methodological
characteristics of these interventions.
Methods
Literature search
We performed database searches and concurrent snowball
searches with the aim of detecting all published Rand-
omized Controlled Trials (RCTs) in which CM had been
applied to people with cancer. The following databases
were searched for papers published in English, Norwe-
gian, Swedish or Danish: PubMed, Embase, Web of Sci-
ence, CINAHL, and The Cochrane Central Register of
Controlled Trials. Articles published all years up to August
2008 were searched for.BMC Health Services Research 2008, 8:227 http://www.biomedcentral.com/1472-6963/8/227
Page 3 of 7
(page number not for citation purposes)
Prior to the search, a batch of possible keywords was
recorded, Thesauruses were examined and definitions
looked up. The following words were searched: "case
management", "case manager", "disease management",
"oncologic nursing", "oncologic nurse", "home care serv-
ices", "advance practice nurse", "advance practice nurs-
ing", "advanced practice nurse", "advanced practice
nursing", "advance nursing", "advanced nurse",
"advanced nursing", "nursing care intervention", "nursing
care interventions", "care coordination", "care coordina-
tor", "patient navigation", "patient navigator", "system
navigation", and "system navigator". The above terms
were combined with "neoplasms" and "cancer".
Due to database construction differences, various combi-
nations of MeSH, key words and text words were used in
the searches. Limiting publication type to "randomized
controlled trial" by the use of a check box was possible in
PubMed and Embase databases, whereas the Cinahl, Web
of Science and Cochrane databases were searched for
RCTs by adding "..."randomly" OR "randomised" OR
"randomized"" (free-text) to the search.
As an example the PubMed search is specified below:
("Case Management" [Mesh] OR "case management" OR
"case manager" OR "Disease Management" [Mesh] OR
"Oncologic Nursing" [Mesh] OR "oncologic nurse" OR
"Home Care Services" [Mesh:noexp] OR "advance prac-
tice nurse" OR "advance practice nursing" OR "advanced
practice nurse" OR "advanced practice nursing" OR
"advance nursing" OR "advanced nurse" OR "advanced
nursing" OR "nursing care intervention" OR "nursing care
interventions" OR "care coordination" OR "care coordi-
nator" OR "patient navigation" OR "patient navigator"
OR "system navigation" OR "system navigator") AND
((("Neoplasms" [Mesh] OR "cancer") AND ((Humans
[Mesh]) AND (English [lang] OR Danish [lang] OR Nor-
wegian [lang] OR Swedish [lang])))) AND ((Randomized
Controlled Trial [ptyp]))
Copies of all database searches can be obtained by con-
tacting the author (CW).
Study selection
We included papers on CM-like interventions that ful-
filled all of the following inclusion criteria:
1) The intervention should meet the criteria for CM which
includes multidisciplinary collaboration, care co-ordina-
tion, and it should include in-person meetings between
patient and the case manager aimed at supporting,
informing and educating the patient.
2) The intervention should focus on cancer patient care (if
other diseases than cancer were included, the majority of
the included patients should suffer from cancer).
3) The intervention should aim to improve subjective or
objective quality outcomes, and effects should be reported
in the paper.
We used the following exclusion criteria: Studies centred
on cancer screening or palliative cancer care.
Data extraction was conducted (without the use of any
software) in order to obtain a descriptive overview of
intervention characteristics, outcomes of interest and
findings. Elements from the CONSORT guidelines and
checklists [20,21] were used to assess elements influenc-
ing internal and external study validity.
Results
Our search identified 654 unique papers, which after ini-
tial assessment (CW) were reduced to 25. These remaining
25 were independently scrutinised for inclusion by PV,
MT and CW. When the reviewers did not agree, the paper
was discussed and consensus reached. Finally, seven
papers were included. Figure 1 illustrates the "flow" of
papers.
Study inclusion and exclusion Figure 1
Study inclusion and exclusion. * Two articles were 
excluded for more than one reason. # Two articles reported 
on already included articles or components hereof.BMC Health Services Research 2008, 8:227 http://www.biomedcentral.com/1472-6963/8/227
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The meticulous review of each included paper is reported
in Tables 1, 2, and 3 (see additional file 1, 2, and 3). CW
primarily filled in the Tables, and MT, PV and CW all read
the included articles and checked the contents of the
tables.
Characteristic elements of interventions are outlined in
Table 1 (Consort items 1–5). Outcomes of interest, statis-
tical methods, baseline data, number of participants ana-
lyzed, and effects found (Consort items 6, 8, 12, 15, 16,
17, and 18) are presented in Table 2. Table 3 presents ele-
ments of study validity found to be important: sample
size, recruitment, random allocation, blinding of assessor,
participant flow (Consort items 7, 14, 9, 11, and 13).
Aspects of generalisability to non-participants are
reported in second column points c) and d).
Main findings
Table 1 audits the characteristics of the seven included
studies. Six trials were conducted in the USA, one in the
UK. Only two of the six papers termed the intervention
"CM" [19,22]. The five other studies were deemed to fulfil
reviewers' inclusion criteria (viz. the quoted CM defini-
tion). Interventions were classified: "advanced practice
nursing" [23,24], "home care interventions" (two were
tested against usual care in a three armed trial [25], "care
coordination" [26], and "nurse-led follow-up" [27].
Despite the different naming, all interventions will be des-
ignated "CM" throughout the rest of this paper.
Two studies [19,23] included breast cancer patients only,
two studies lung cancer patients only [25,27]. The last
three included different cancer types of which one trial
[26] also addressed other advanced illness (chronic
obstructive pulmonary disease (COPD) and chronic heart
failure (CHF)). Two studies tested hospital-to-community
interventions [19,23], and three studies tested community
interventions [22,24,25]. One study [27] tested a hospital
(in-patient) intervention. The setting for one study was
unclear, but the text implies an in-patient setting [26].
Health care professionals performed all interventions and
nurses exclusively performed the intervention in five trials
[19,22-24,27]. In one study, a nurse education was not a
prerequisite to performing the intervention [26]. In
another study [25] (the three-armed RCT), nurses were
members of the intervention teams which included vari-
ous professions.
Six studies described some sort of model, manual and/or
use of supportive tools, e.g. assessment tool or checklist
(Table 2). The sixth study [25] reported no such use of
manual or tools, and offered no precise description of
intended and performed intervention.
The patients' GPs were only expressly mentioned in the
study from the UK [27]. This study also evaluated the
intervention in terms of the GPs' satisfaction.
Table 2 presents outcomes studies. First of all, it is note-
worthy that only three articles [19,24,27] mentioned
which outcomes were primary and which were secondary.
Since there is no overlap of outcomes studied (tool and
methods of assessment) between the trials, no synthesis of
effects can be made.
To further evaluate the effects, outcomes were divided
(our own categories) into objective and subjective (=
patient reported) elements. Objective elements studied
included: survival [24,27], received therapy [19], physical
function (arm function) [19], advance directives and "do-
not-resuscitate and intubate"-wishes [26], service use and
hospitalization [22,25,27], and costs [23,26,27]. Subjec-
tive elements studied included: patient-reported needs
and symptoms [22,25], patient-reported "quality of life"
[22,24,27], patient satisfaction and evaluation of the deci-
sion-making process [19,26,27], and relative-reported
problems experienced in the interaction with the health
care system [26].
When categorising outcomes according to the above crite-
ria and taking nothing else into account, some dimen-
sions of Quality of Life appeared to be improved.
Similarly, all three papers reporting patient satisfaction
reported improvements.
Looking at Table 3, it is obvious that validity elements of
interventions were inadequately reported in most papers.
Sample size measures were only reported in one paper
[27], and one or more of the following elements were
only poorly described: recruitment, allocation conceal-
ment method and blinding of assessor. Moreover, patient
flows were incomprehensible in all papers except for one
[27], which also included a flow diagram. All articles ana-
lysed whether randomization was successful regarding
baseline covariates (Table 2).
Discussion
Principal findings
Only seven studies evaluating the effect of CM or a CM-
like-intervention applied to cancer care were found.
Studies diverged much in terms of target group, interven-
tion setting, outcomes measured and findings.
Some of the included studies reported improvements in
patient satisfaction and dimensions of quality of life
measures. However, the methods used to measure the
effects were all different (tool and method of assessment)
and validity of many of the tools was poor or unknown.BMC Health Services Research 2008, 8:227 http://www.biomedcentral.com/1472-6963/8/227
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All in all, overall study validity was inadequate. Due to the
heterogeneity of the studies found, it was hardly possible
to score validity in a simple measure or to make a meta-
analysis of the results.
Thus, no conclusions can be made about the effect of CM
on cancer patient care on the present basis.
Strengths and weaknesses of this review
The weak definition of CM and detection of interventions
not specifically labelled "CM" but imitating CM forced us
to search for more terms than just "case management" and
"case manager". Papers on patient and system navigation
were considered to conceal CM interventions and were
accordingly included. However, no navigation papers
passed the study selection criteria. Our search made us
realize that navigation studies primarily address screening
and follow-up of abnormal screening findings among
poor, vulnerable people [28].
Our widened search strategy is regarded as a strength, but
it also blurred the convenient clear-cut boundary between
which interventions to include and which to exclude.
Despite the fact that the intervention by Mor et al [22] was
one of the only two included articles categorised "CM",
the tested educational short-term CM intervention
included very few multidisciplinary components which
normally makes it possible to distinguish CM from other
nursing care.
Palliative care where the focus is on "care-alleviating
symptoms and not on curing the underlying disease" is
regarded as an exclusive, medical and research discipline
(with supportive elements resembling CM) for which rea-
son such studies were not included [29]. Also, the ration-
ale for not including palliative care CM intervention was
rooted in our perception that a patient in a care situation
involving diagnosing, treatment and follow-up and facing
potential cure is experiencing problems other than those
faced by a palliative care patient. Thus, our aim was to illu-
minate CM interventions targeting cancer patients early in
their disease trajectories. It should be emphasized that our
decision is not tantamount to claiming that it is irrelevant
to test CM-like interventions in the palliative care setting.
Publication bias and inclusion of RCTs only may have
reduced the number of papers found.
Publication bias is always a problem when conducting
systematic reviews and performing meta-analyses. Theo-
retically, the temptation not to publish negative results of
a study may be greater in the case of complex interven-
tions than simple interventions because it is more difficult
to describe the components of a complex intervention.
The present review is delimited to RCTs because this
research design is considered to be superior to other trials
when it comes to trusting reported effect estimates
[30,31]. On the other hand, a decision to include RCTs
only may be questioned when the aim is to evaluate com-
plex intervention of which CM form part because of pos-
sible reproducibility problems regarding intervention
content. It may be difficult to reproduce outcomes when
the intervention tested is poorly described. MRC has set
up a framework for developing complex interventions to
be tested in the RCT [32,33]. When MRC's framework is
followed, the RCT design can be regarded as a "gold stand-
ard", also for complex interventions.
None of included papers mentioned MRC's framework,
but several made an effort to minimize the "black box"
[18,34].
Manuals, tools and accounts of actually conducted activi-
ties (type and dosage) are essential to minimize the "black
box". As mentioned, six studies described some sort of
model, manual and/or use of supportive tools, e.g. assess-
ment tool or checklist (Table 2). Moreover, three papers
described attempts to check which CM activities had actu-
ally been conducted. Engelhardt et al [26] described that
care coordinators completed checklists which afterwards
were checked for intervention integrity. McCorkle et al
[24] calculated and grouped nursing intervention (assess-
ment, education, etc.) and the work by Goodwin et al [19]
was succeeded by a paper based on intervention contacts
[35].
Comparisons with other studies
Summaries of nursing and CM interventions have previ-
ously been made, but this is the first review of CM targeted
at cancer patients. A literature review from 2004 on evi-
dence-based nursing interventions applied to older adults
who had cancer [36] concluded that the body of literature
was small and heterogeneous. Among the studies summa-
rized, two [19,24] were also included in our review.
Other reviews of CM seem to originate in the disease or
the setting.
Two reviews of disease-specific CM have been conducted:
A review of CM for people with diabetes concluded that
CM was effective in improving both glycaemic control
and provider monitoration of glycaemic control for adults
with type 2 diabetes both when delivered in conjunction
with disease management and when delivered with one or
more additional educational, reminder, or support inter-
ventions (setting: U.S. managed care) [1].
A review of nurse-led disease management for people with
chronic obstructive pulmonary disease (COPD) con-BMC Health Services Research 2008, 8:227 http://www.biomedcentral.com/1472-6963/8/227
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cluded that: "There is little evidence to date to support the
widespread implementation of nurse led management
interventions for COPD, but the data are too sparse to
exclude any clinically relevant benefit or harm arising
from such interventions" [37].
Two papers on in-patient/hospital (setting-specific) CM
were found: A meta-analysis from 2005 on the effect of
CM on hospital length-of-stay (LOS) and readmission
concluded that hospital-based CM was not effective in
reducing LOS and the percentage of patients readmitted at
least once. The meta-analysis included 12 experimental
studies, none of which focused on cancer patients [38].
Similarly, a research synthesis of in-patient CM (from
1998) did not support that effectiveness was improved in
terms of patient and provider satisfaction, quality-of-care,
cost savings and length of stay (the study included 13
quasi-experimental and five randomized trials) [39].
Conclusion
The purpose of CM is to optimize individual cost-effective
quality care for patients suffering from chronic and/or
complex diseases.
Generally, reviews on the effects of CM in somatic care
have found inconclusive positive effects.
This is the first review studying CM applied in cancer
patient care. Due to the scarcity of papers included
(seven), significant heterogeneity of CM interventions
and effects studied, and the methodological inadequacies,
no conclusions on the effects of CM in cancer patient care
can be made.
Further evaluations of CM in cancer patient care are
needed. Future research needs to focus on the elimination
of the "black box" through thorough descriptions and
reporting of interventions. Instead of starting from
scratch, CM developers are recommended to build
research on existing models, outcome-tools and comple-
mentary research findings. Additionally, re-testing inter-
ventions in various settings could be interesting.
Following MRC's framework [32] when designing and
evaluating complex interventions is recommended.
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